MILLENNIUM PARTNERS: Form 8.3 - Allergan plc
07 Mai 2020 - 4:15PM
UK Regulatory
TIDM0Y7T
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Millennium International Management LP
Company dealt in Allergan plc
Class of relevant security to which IE00BY9D5467
the dealings being disclosed relate
(Note 2)
Date of dealing 6(th) May 2020
1. INTERESTS AND SHORT POSITIONS
1. Interests and short positions (following dealing) in the class ofrelevant
security dealt in(Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 4,445,227 2,705
(1.350%) (0.001%)
(2) Derivatives (other than options) - -
(3) Options and agreements to purchase/sell - -
Total 4,445,227 2,705
(1.350%) (0.001%)
1. Interests and short positionsin relevant securitiesof the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
1. Purchases and sales
Price per unit (Note 5)
Purchase/sale Number of relevant securities (USD)
Sale 200 194.10
Sale 33 194.11
Sale 100 194.09
Sale 396 195.00
Purchase 792 193.89
Purchase 9 195.03
Purchase 100 195.81
Purchase 385 195.04
Purchase 15 195.47
Purchase 1,061 194.62
Purchase 6 195.90
Purchase 65 194.68
Purchase 6 195.94
Purchase 276 195.72
Purchase 117 195.11
Purchase 74 195.79
Purchase 190 195.71
Purchase 210 195.62
Purchase 2,305 195.55
Purchase 365 195.35
Purchase 405 195.45
Purchase 13 195.53
Purchase 300 194.24
Purchase 800 194.95
Purchase 19 194.14
Purchase 800 194.81
Purchase 260 194.78
Purchase 527 195.74
Purchase 2 194.13
Purchase 112 194.31
Purchase 1,100 194.45
Purchase 264 195.56
Purchase 200 195.48
Purchase 400 194.48
Purchase 1,400 195.59
Purchase 1,000 195.78
Purchase 151 194.67
Purchase 69 193.89
Purchase 100 195.14
Purchase 379 194.29
Purchase 281 194.46
Purchase 100 195.27
Purchase 100 195.77
Purchase 100 195.47
Purchase 100 195.60
Purchase 100 195.62
Purchase 100 195.10
Purchase 100 195.23
Sale 2 195.23
Purchase 100 195.45
Sale 2 195.22
Purchase 178 194.05
Sale 360 194.13
Sale 1 195.46
Purchase 260 194.11
Sale 3 194.99
Sale 4 194.93
Sale 11 194.79
Purchase 1 194.41
Sale 1 194.91
Sale 18 194.88
Sale 1 194.71
1. Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
1. Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
None.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 7(th) May 2020
Contact name Milos Naumovic
Telephone number +44 203 650 8203
If a connected EFM, name of offeree/offeror with which
connected
If a connected EFM, state nature of connection (Note 10)
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200507005625/en/
CONTACT:
Millennium Partners, L.P.
SOURCE: Millennium Partners, L.P.
Copyright Business Wire 2020
(END) Dow Jones Newswires
May 07, 2020 10:15 ET (14:15 GMT)
Allergan (LSE:0Y7T)
Graphique Historique de l'Action
De Mar 2025 à Avr 2025
Allergan (LSE:0Y7T)
Graphique Historique de l'Action
De Avr 2024 à Avr 2025
